X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Tissue-specific metabolic profile drives iNKT cell function during obesity and liver injury.

Cristhiane Favero Aguiar | Felipe Corrêa-da-Silva | Michelangelo Bauwelz Gonzatti | Monara Kaelle Angelim | Marco Antonio Pretti | Gustavo Gastão Davanzo | Bianca Gazieri Castelucci | Lauar Brito Monteiro | Gisele Castro | João Victor Virgilio-da-Silva | Guilherme Ribeiro | Vitor Jaccomo | Mirella C Pereira Andrade | Webster Leonardo Costa | Victor Gambarini | Fernanda Fernandes Terra | José Carlos Alves-Filho | Niels Olsen Saraiva Câmara | Mariana Boroni | Alexandre Castro Keller | Pedro M Moraes-Vieira
Cell reports | 2023

Invariant natural killer T (iNKT) cells are a distinct population of lymphocytes characterized by their reactivity to glycolipids presented by CD1d. iNKT cells are found throughout the body, and little is known about their tissue-specific metabolic regulation. Here, we show that splenic and hepatic iNKT cells are metabolically comparable and rely on glycolytic metabolism to support their activation. Deletion of the pyruvate kinase M2 (Pkm2) gene in splenic and hepatic iNKT cells impairs their response to specific stimulation and their ability to mitigate acute liver injury. In contrast, adipose tissue (AT) iNKT cells exhibit a distinctive immunometabolic profile, with AMP-activated protein kinase (AMPK) being necessary for their function. AMPK deficiency impairs AT-iNKT physiology, blocking their capacity to maintain AT homeostasis and their ability to regulate AT inflammation during obesity. Our work deepens our understanding on the tissue-specific immunometabolic regulation of iNKT cells, which directly impacts the course of liver injury and obesity-induced inflammation.

Pubmed ID: 36848232 RIS Download

Additional research tools detected in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


IL-10 (antibody)

RRID:AB_2738582

This monoclonal targets IL-10

View all literature mentions

PE anti-mouse CD36 (antibody)

RRID:AB_389348

This monoclonal targets CD36

View all literature mentions

APC anti-mouse IFN-gamma (antibody)

RRID:AB_315404

This monoclonal targets IFN-gamma

View all literature mentions

PE/Cyanine7 anti-mouse IL-4 (antibody)

RRID:AB_10898116

This monoclonal targets IL-4

View all literature mentions

APC anti-mouse IL-12/IL-23 p40 (antibody)

RRID:AB_315370

This monoclonal targets IL-12/IL-23 p40

View all literature mentions

PE/Cyanine7 anti-mouse Ly-6C (antibody)

RRID:AB_1732082

This monoclonal targets Ly-6C

View all literature mentions

APC anti-mouse CD206 (MMR) (antibody)

RRID:AB_10900231

This monoclonal targets CD206

View all literature mentions

BV421 Rat Anti-Mouse F4/80 (antibody)

RRID:AB_2734779

This monoclonal targets F4/80

View all literature mentions

PE anti-mouse CD11c (antibody)

RRID:AB_313777

This monoclonal targets CD11c

View all literature mentions

CD45 (antibody)

RRID:AB_394611

This monoclonal targets CD45

View all literature mentions

B6;129S-Gt(ROSA)26Sortm1(CAG-COX8A/Dendra2)Dcc/J (organism)

RRID:IMSR_JAX:018385

Mus musculus with name B6;129S-Gt(ROSA)26Sortm1(CAG-COX8A/Dendra2)Dcc/J from IMSR.

View all literature mentions

STOCK Prkaa1tm1.1Sjm/J (organism)

RRID:IMSR_JAX:014141

Mus musculus with name STOCK Prkaa1tm1.1Sjm/J from IMSR.

View all literature mentions

B6;129S-Pkmtm1.1Mgvh/J (organism)

RRID:IMSR_JAX:024048

Mus musculus with name B6;129S-Pkmtm1.1Mgvh/J from IMSR.

View all literature mentions

B6.Cg-Tg(Cd4-cre)1Cwi/BfluJ (organism)

RRID:IMSR_JAX:022071

Mus musculus with name B6.Cg-Tg(Cd4-cre)1Cwi/BfluJ from IMSR.

View all literature mentions